New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management

Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting

(2013) Jerrold H. Levy et al.   ANESTHESIOLOGY

Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment

(2013) Jochen Graff et al.   CLINICAL PHARMACOKINETICS

Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity

(2013) William E. Dager et al.   CRITICAL CARE MEDICINE

Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis

(2013) Anne-Céline Martin et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Advantages and limitations of the new anticoagulants

(2013) S. Schulman   JOURNAL OF INTERNAL MEDICINE

Laboratory testing for the new oral anticoagulants: a review of current practice

(2013) Emmanuel J. Favaloro et al.   PATHOLOGY

Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates

(2013) András Gruber et al.   THROMBOSIS AND HAEMOSTASIS

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

(2013) Christian Chatelain et al.   THROMBOSIS AND HAEMOSTASIS

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

(2012) Scott Kaatz et al.   AMERICAN JOURNAL OF HEMATOLOGY

How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch

(2012) S. Schulman et al.   BLOOD

How I treat anticoagulated patients undergoing an elective procedure or surgery

(2012) A. C. Spyropoulos et al.   BLOOD

Guideline on the management of bleeding in patients on antithrombotic agents

(2012) Mike Makris et al.   BRITISH JOURNAL OF HAEMATOLOGY

Perioperative Management of Antithrombotic Therapy

(2012) James D. Douketis et al.   CHEST

The use of FEIBA®in the correction of coagulation abnormalities induced by dabigatran

(2012) T.-L. Khoo et al.   International Journal of Laboratory Hematology

Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model

(2012) I. PRAGST et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy

(2012) A. C. SPYROPOULOS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate

(2012) M. D. LAMBOURNE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Determination of Dabigatran in Human Plasma Samples

(2012) Job Harenberg et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Determination of Rivaroxaban in Human Plasma Samples

(2012) Job Harenberg et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation

(2012) Martine Wolf et al.   THROMBOSIS AND HAEMOSTASIS

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

(2012) Raphael Marlu et al.   THROMBOSIS AND HAEMOSTASIS

Impact of dabigatran on a large panel of routine or specific coagulation assays

(2012) Séverine Robert et al.   THROMBOSIS AND HAEMOSTASIS

Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

(2012) A. G. G. Turpie et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model

(2011) Anne Godier et al.   ANESTHESIOLOGY

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Rivaroxaban

(2011) Wolfgang Mueck et al.   CLINICAL PHARMACOKINETICS

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

(2011) Wei Zhou et al.   STROKE

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

(2010) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology

(2010) Wiebke Gogarten et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

(2010) Marcel Levi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

(2010) Fariba Baghaei et al.   THROMBOSIS AND HAEMOSTASIS

Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

(2009) Joachim Stangier et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE